Fund Holdings — Lion Point Capital, LP

Total Portfolio Value
$111.97M
Total Bought
$11.68M
Total Sold
$11.18M
Net Transaction
+$499.9K
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
MARINUS PHARMACEUTICALS INC2,145,3372,134,337-11,00017,27023,20020.72%+5,930
ARDELYX INC1,176,6671,151,667-25,0004,8017,1406.38%+2,340
HARPOON THERAPEUTICS INC82,458228,900+146,4423322,6032.32%+2,270
MILESTONE PHARMACEUTICALS IN(MIST)450,2071,650,207+1,200,0001,3962,7562.46%+1,360
ENPHYS ACQUISITION CORP078,125+78,12508340.74%+834
CYMABAY THERAPEUTICS INC82,42582,42501,2291,9471.74%+718
FENNEC PHARMACEUTICALS INC(FENC)110,000110,00008261,2341.10%+408
INSMED INC(INSM)70,33570,33501,7762,1801.95%+404
AVADEL PHARMACEUTICALS PLC80,00080,00008241,1301.01%+306
SYNDAX PHARMACEUTICALS INC(SNDX)34,50034,50005017460.67%+245
AMYLYX PHARMACEUTICALS INC(AMLX)014,000+14,00002060.18%+206
BURGERFI INTERNATIONAL INC02,083,438+2,083,4380940.08%+94
TRAVERE THERAPEUTICS INC(TVTX)0006486710.60%+23
KINIKSA PHARMACEUTICALS LTD130,691130,69102,2702,2922.05%+22
MICROSOFT CORP(MSFT)100100032380.03%+6
TRAVERE THERAPEUTICS INC(TVTX)78,00078,00006977010.63%+4
ALPHABET INC(GOOG)100100013140.01%+1
CHEVRON CORP NEW(CVX)460-4680—-8
LUMOS PHARMA INC90,79490,79403002890.26%-11
HUMACYTE INC(HUMA)235,000235,00006896670.60%-21
BATTALION OIL CORPORATION(BATL)380,891222,182-158,7092,3542,1351.91%-219
AADI BIOSCIENCE INC(WHWK)82,42382,42303991660.15%-232
REPLIMUNE GROUP INC(REPL)35,00042,500+7,5005993580.32%-241
MIRUM PHARMACEUTICALS INC(MIRM)27,00013,500-13,5008533990.36%-455
ACLARIS THERAPEUTICS INC(ACRS)115,898115,89807941220.11%-672
BURGERFI INTERNATIONAL INC2,745,9382,745,93803,1852,3612.11%-824
BLUEBIRD BIO INC531,256531,25601,6157330.65%-882
DURECT CORP427,4550-427,4551,0640—-1,064
SERES THERAPEUTICS INC(MCRB)691,803340,761-351,0421,6464770.43%-1,169
SEMTECH CORP(SMTC)2,452,8552,577,855+125,00063,16156,48150.44%-6,680
Page 1 of 1
Lion Point Capital, LP — 13F Holdings — Q4 2023 | TickerTrail